Thomson Reuters Sells Healthcare Division | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Thomson Reuters Sells Healthcare Division

April 23, 2012
by Gabriel Perna
| Reprints

Thomson Reuters, a New York-based provider of information systems for numerous industries, including hospitals and healthcare providers, is selling its healthcare business to New York-based Veritas Capital for $1.25 billion in cash. The sale is subject to regulatory approval and customary closing conditions and is expected to close in the next few months. The sale is not subject to any financing condition. Veritas has obtained debt financing commitments for the transaction.

Thomson Reuters’ healthcare business provides data, analytics, and performance benchmarking solutions and services to hospitals, health systems, employers, health plans, government agencies, and healthcare professionals. It has solutions such as MarketScan, Advantage Suite, Micromedex, CareDiscovery, and ActionOI, and consulting services as well.

"We are proud of our colleagues who built a very strong Healthcare business," James C. Smith, chief executive officer of Thomson Reuters, said in a statement. "I know they will continue to serve their customers with the same high standards under new ownership. With the completion of the divestiture, Thomson Reuters will be even more focused on our core global businesses."

Morgan Stanley and Allen & Company are acting as financial advisors to Thomson Reuters for the proposed divestiture.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).